World-wide medical news for clinical use. Contributions edited by Dr.A.Franklin MBBS(Lond)Dip.Phys.Med (UK) DPH & DIH(Tor.)LMC(C) FLEx(USA) Fellow Med.Soc.London
26 February 2014
FREE WEBINAR:IMMUNOGLOBULIN Heavy/Light Chain Assay.
The Binding Site Group Ltd
Hevylite® Webinar by Key Opinion Leader and Live Q & A Session
‘The Immunoglobulin Heavy/Light Chain (Hevylite) assay for diagnosis, response evaluation, and evaluation of biological aspects of multiple myeloma’
Presented by University Professor Dr Heinz Ludwig
Wilhelminenspital, Vienna, Austria
Dr_Heinz_Ludwig_with_Dr_Stephen_Harding
Professor Dr Heinz Ludwig with Dr Stephen Harding, Research & Development Director at
Binding Site Headquarters Birmingham, UK
Monday 10th March 2014
07:00PM - 08:00PM GMT
Register Now
OR
Tuesday 11th March 2014
10:00AM - 11:00AM GMT
Register Now
What will you learn from this webinar?
The Hevylite assay improves detection and measurement of monoclonal proteins that are:
Difficult to quantify by electrophoresis
At low levels
How to improve monitoring of Multiple Myeloma patients with Hevylite
The Hevylite ratio lets you:
Assess the presence of monoclonal protein production over polyclonal protein production
Identify residual disease in some cases that are negative by electrophoresis
Detect relapse in some cases where electrophoresis is negative
After the webinar, keep listening for a Live Question & Answer Session with Binding Site's Research & Development Director, Dr Stephen Harding, who developed the Hevylite assay.
View our Disclaimer.
There is no fee to attend this webinar. After registering you will receive a confirmation email containing information about joining the webinar.
System Requirements
PC-based attendees require: Windows® 8, 7, Vista, XP or 2003 Server
Macintosh® based attendees require: Mac OS® X 10.6 or newer
Mobile attendees require: iPhone®, iPad®, Android™ phone or tablet
Binding Site - Committed to improving patient lives worldwide
through education, collaboration & innovation
Subscribe to:
Posts (Atom)